19/03/2017 - 08:48

MGC Pharma raises $10m to fast-track medical cannabis development

19/03/2017 - 08:48

Bookmark

Save articles for future reference.

Medicinal cannabis player MGC Pharma has easily raised $10 million as it looks to fast-track acquisitions and accelerate development of its cannabis-derived products. MGC will use the funds to ramp up its medical R&D program and expand sales of its cosmetics and dermatological cannabis-derived lines with the latter to fund the former.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options